Postpartum hemorrhage: new management options.
Dildy
Gary A
GA
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. gdildy3@lsuhsc.edu
D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D002260:Carboprost / Q000627:therapeutic use; D015232:Dinoprostone / Q000627:therapeutic use; D004338:Drug Combinations; D004621:Embolization, Therapeutic; D004638:Emergency Treatment; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008755:Methylergonovine / Q000627:therapeutic use; D010121:Oxytocin / Q000627:therapeutic use; D010921:Placenta Accreta / Q000000981:diagnostic imaging / Q000517:prevention & control*; D006473:Postpartum Hemorrhage / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery; D011247:Pregnancy; D011312:Pressure; D011453:Prostaglandins / Q000627:therapeutic use; D014325:Tromethamine / Q000627:therapeutic use; D016216:Ultrasonography, Prenatal
D004338:Drug Combinations; D004876:Ergot Alkaloids; D011453:Prostaglandins; D014325:Tromethamine; D010121:Oxytocin; D002260:Carboprost; D015232:Dinoprostone; C062843:carboprost tromethamine; D008755:Methylergonovine